Role of Early Treatment and Gaps in Heart Failure Diagnosis
The role of early aggressive treatment in preventing progression of heart failures and the importance of understanding the root cause of disease.
SMA Resources for Physicians and Families
Several spinal muscular atrophy (SMA) resources are suggested to help physicians and families: Cure SMA, SMArt Moves, SMA Standard of Care documents, and the Child Neurology Foundation’s Telehealth Tip Sheet.
Hallmark Signs of SMA in Pediatric Patients
Experts suggest what to look for during a virtual examination during COVID-19 that may suggest a diagnosis of spinal muscular atrophy (SMA). If SMA is suspected, they stress the importance of an evaluation, as soon as possible, with a neurologist.
Use of Telehealth to Address Parental Concerns
Garey H. Noritz, MD, stresses the value of in-person office visits for babies to ensure they receive their vaccinations and physical examination.
Increasing Patient Adherence to Schizophrenia Treatment Regimen
Rahn Bailey, MD, DFAPA, and Henry Nasrallah, MD, explain how to increase patient adherence to treatment and address the stigma associated with schizophrenia even in the family of the patient.
Schizophrenia Relapse: Diagnosis, Prevention, and Impact
Henry Nasrallah, MD, examines schizophrenia relapse, specifically how to diagnose and prevent it before further damage has transpired in the patient’s brain.
New Labeling Requirements Put Forth by the FDA for Opioids
Theresa Mallick-Searle, MS, RN-BC, ANP-BC, shares her perspective on the new labeling requirements put forth by the FDA for opioids in regards to naloxone.
Risks for Accidental Opioid Overdose Seen in the Community
Joshua Lynch, DO, EMT-P, FAAEM, FACEP, highlight risks he has seen in the community for unintended users as well as patients for accidental opioid overdose.
Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, discuss whether children outgrow atopic dermatitis and advice for the management of disease.
Optimizing Care for ADHD During COVID-19
Optimizing care and managing challenges for patients with ADHD during the COVID-19 pandemic and advice for clinicians educating patients and families on disease management.
Addressing Drug Holidays for ADHD Medication
Rakesh Jain, MD, MPH, shares his thoughts on whether drug holidays are appropriate for children taking medication for ADHD.
Approaching ADHD Treatment Selection in Children and Adults
Rakesh Jain, MD, MPH, considers the evidence-based recommended hierarchy in the choice of medications for the treatment of pediatric and adult ADHD.
FDA-Approved Medications for ADHD
Andrew J. Cutler, MD, reviews currently available stimulants and nonstimulants as well as their safety and efficacy for the treatment of ADHD.
Benefits of a Multimodal Treatment Approach to ADHD
Rakesh Jain, MD, MPH, shares his thoughts on the importance of combining pharmacological and non-pharmacological treatments for the management of ADHD.